Rolf I. Skotheim

Citée par

	Toutes	Depuis 2020
Citations	8758	3206
indice h	53	31
indice i10	93	70

740

370

185

555

2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202548 44 91 100 115 165 172 212 336 385 429 526 530 524 538 568 683 738 652 638 571 540 65

Accès public

Tout afficher

44 articles

5 articles

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Arild NesbakkenProfessor, Gastrointestinal surgery, Oslo University HospitalAdresse e-mail validée de medisin.uio.no
Manuel TeixeiraIPO-Porto and University of Porto, Porto, PortugalAdresse e-mail validée de ipoporto.min-saude.pt
Olli KallioniemiDirector, Science for Life Laboratory and the data-driven life science programAdresse e-mail validée de scilifelab.se
Ola MyklebostProfessor Cancer Biology, University of BergenAdresse e-mail validée de uib.no
Marthe LøvfAdresse e-mail validée de rr-research.no
Rui HenriqueProfessor of Pathology, University of PortoAdresse e-mail validée de icbas.up.pt
Espen Thiis-EvensenOslo University HospitalAdresse e-mail validée de ous-hf.no
Jarle BruunOslo University Hospital, The Norwegian Radium Hospital, Institute for Cancer ResearchAdresse e-mail validée de rr-research.no
Leonardo A. Meza-ZepedaDepartment Head, Institute for Cancer Research, Oslo University HospitalAdresse e-mail validée de ous-research.no
João Diogo Barros SilvaPostdoctoral scientist, University of BirminghamAdresse e-mail validée de bham.ac.uk
Torfinn NomeUniversity of OsloAdresse e-mail validée de usit.uio.no
Sharmini AlagaratnamProgramme director, Healthcare programme, Group Technology & Research, DNV GLAdresse e-mail validée de dnv.com
Peter W AndrewsArthur Jackson Professor of Biomedical Science, The University of SheffieldAdresse e-mail validée de sheffield.ac.uk
Paula PauloPortuguese Oncology Institute of PortoAdresse e-mail validée de ipoporto.min-saude.pt
Fredrik MertensDepartment of Clinical Genetics, Lund UniversityAdresse e-mail validée de med.lu.se
Reija AutioTampere UniversityAdresse e-mail validée de tuni.fi
Matthias NeesUniversity of TurkuAdresse e-mail validée de utu.fi
Knut LiestølUniversity of OsloAdresse e-mail validée de ifi.uio.no
Rajpert-De Meyts, EwaCopenhagen University Hospital - RigshospitaletAdresse e-mail validée de regionh.dk
Kristina Totland CarmOslo University HospitalAdresse e-mail validée de rr-research.no

Suivre

Rolf I. Skotheim

Dept. Molecular Oncology, Institute for Cancer Research, Oslo University Hospital-Radiumhospitalet

Adresse e-mail validée de uio.no - Page d'accueil

Cancer research bioinformatics genomics prostate cancer transcriptomics


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes A Sveen, S Kilpinen, A Ruusulehto, RA Lothe, RI Skotheim Oncogene 35 (19), 2413-2427, 2016	508	2016
Multi-omics of 34 colorectal cancer cell lines-a resource for biomedical studies KCG Berg, PW Eide, IA Eilertsen, B Johannessen, J Bruun, SA Danielsen, ... Molecular cancer 16, 1-16, 2017	379	2017
Systematic bioinformatic analysis of expression levels of 17,330 human genes across 9,783 samples from 175 types of healthy and pathological tissues S Kilpinen, R Autio, K Ojala, K Iljin, E Bucher, H Sara, T Pisto, M Saarela, ... Genome biology 9, 1-14, 2008	331	2008
TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming K Iljin, M Wolf, H Edgren, S Gupta, S Kilpinen, RI Skotheim, M Peltola, ... Cancer research 66 (21), 10242-10246, 2006	309	2006
Alternative splicing in cancer: noise, functional, or systematic? RI Skotheim, M Nees The international journal of biochemistry & cell biology 39 (7-8), 1432-1449, 2007	279	2007
ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis TH Ågesen, A Sveen, MA Merok, GE Lind, A Nesbakken, RI Skotheim, ... Gut 61 (11), 1560-1567, 2012	269	2012
PtdIns (3) P controls cytokinesis through KIF13A-mediated recruitment of FYVE-CENT to the midbody AP Sagona, IP Nezis, NM Pedersen, K Liestøl, J Poulton, TE Rusten, ... Nature cell biology 12 (4), 362-371, 2010	266	2010
Oncogenicity of the developmental transcription factor Sox9 A Matheu, M Collado, C Wise, L Manterola, L Cekaite, AJ Tye, ... Cancer research 72 (5), 1301-1315, 2012	265	2012
Differentiation of Human Embryonal Carcinomas In vitro and In vivo Reveals Expression Profiles Relevant to Normal Development RI Skotheim, GE Lind, O Monni, JM Nesland, VM Abeler, SD Fosså, ... Cancer research 65 (13), 5588-5598, 2005	240	2005
Three Epigenetic Biomarkers, GDF15, TMEFF2, and VIM, Accurately Predict Bladder Cancer from DNA-Based Analyses of Urine Samples VL Costa, R Henrique, SA Danielsen, S Duarte-Pereira, M Eknaes, ... Clinical Cancer Research 16 (23), 5842-5851, 2010	212	2010
New insights into testicular germ cell tumorigenesis from gene expression profiling RI Skotheim, O Monni, S Mousses, SD Fosså, OP Kallioniemi, RA Lothe, ... Cancer research 62 (8), 2359-2364, 2002	202	2002
Meta-analysis identifies four new loci associated with testicular germ cell tumor CC Chung, PA Kanetsky, Z Wang, MAT Hildebrandt, R Koster, ... Nature genetics 45 (6), 680-685, 2013	199	2013
Multifocal primary prostate cancer exhibits high degree of genomic heterogeneity M Løvf, S Zhao, U Axcrona, B Johannessen, AC Bakken, KT Carm, ... European urology 75 (3), 498-505, 2019	187	2019
BCL-XL mediates the strong selective advantage of a 20q11. 21 amplification commonly found in human embryonic stem cell cultures S Avery, AJ Hirst, D Baker, CY Lim, S Alagaratnam, RI Skotheim, ... Stem cell reports 1 (5), 379-386, 2013	186	2013
Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas GE Lind, SA Danielsen, T Ahlquist, MA Merok, K Andresen, RI Skotheim, ... Molecular cancer 10, 1-15, 2011	186	2011
MiR-9,-31, and-182 deregulation promote proliferation and tumor cell survival in colon cancer L Cekaite, JK Rantala, J Bruun, M Guriby, TH Ågesen, SA Danielsen, ... Neoplasia 14 (9), 868-IN21, 2012	170	2012
Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers T Ahlquist, GE Lind, VL Costa, GI Meling, M Vatn, GS Hoff, TO Rognum, ... Molecular cancer 7, 1-11, 2008	155	2008
ColoGuidePro: a prognostic 7-gene expression signature for stage III colorectal cancer patients A Sveen, TH Ågesen, A Nesbakken, GI Meling, TO Rognum, K Liestøl, ... Clinical cancer research 18 (21), 6001-6010, 2012	137	2012
MicroRNAs as growth regulators, their function and biomarker status in colorectal cancer L Cekaite, PW Eide, GE Lind, RI Skotheim, RA Lothe Oncotarget 7 (6), 6476, 2015	127	2015
Meta-analysis of five genome-wide association studies identifies multiple new loci associated with testicular germ cell tumor Z Wang, KA McGlynn, E Rajpert-De Meyts, DT Bishop, CC Chung, ... Nature genetics 49 (7), 1141-1147, 2017	116	2017

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs